Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• Cyclic nucleotide phosphodiesterases (PDEs) regulate intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).
• The PDE superfamily comprises multiple families with distinct structures and substrate specificities.
• Understanding novel PDE families is crucial for elucidating cellular signaling pathways.

Purpose of the Study:

• To clone, express, and characterize the novel human phosphodiesterase PDE11A1.
• To investigate the substrate specificity and kinetic properties of PDE11A1.
• To determine the tissue distribution and potential isoforms of PDE11A.

Main Methods:

• Cloning and expression of human PDE11A1 cDNA.
• Biochemical characterization of recombinant PDE11A1 enzyme activity.
• Western blotting and Northern blotting for tissue distribution analysis.

Main Results:

• Human PDE11A1 cDNA encodes a 490-amino acid protein with a unique GAF domain.
• PDE11A1 exhibits dual-substrate activity, hydrolyzing both cAMP and cGMP with similar kinetics.
• PDE11A mRNA and protein isoforms are detected in various human tissues, including skeletal muscle and prostate.

Conclusions:

• PDE11A represents a distinct PDE family with dual substrate specificity, potentially regulating both cAMP and cGMP signaling.
• The presence of multiple transcripts and protein isoforms suggests complex regulation and function of PDE11A.
• PDE11A is a potential therapeutic target due to its involvement in cyclic nucleotide signaling.